Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 38 | $11,209,066 |
| Sells | 0 | $0 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 27 Aug 2024 14:46 | HQL | abrdn Life Sciences Investors | MAHER BILL | Director | 23 Aug 2024 | Purchase | 650 | 15.37 | 9,990 | I |
| 18 Jul 2024 14:56 | HQL | abrdn Life Sciences Investors | DIMARTINO ROSE | Director | 16 Jul 2024 | Purchase | 1,000 | 15.53 | 15,530 | D |
| 27 Jun 2024 11:22 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 26 Jun 2024 | Purchase | 100 | 14.07 | 1,407 | I |
| 25 Jun 2024 17:36 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 24 Jun 2024 | Purchase | 13,812 | 14.08 | 194,473 | I |
| 14 Jun 2024 13:59 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 13 Jun 2024 | Purchase | 8,467 | 13.82 | 117,014 | I |
| 14 Jun 2024 13:59 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 12 Jun 2024 | Purchase | 2,400 | 13.88 | 33,312 | I |
| 11 Jun 2024 17:03 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 11 Jun 2024 | Purchase | 2,039 | 13.76 | 28,057 | I |
| 11 Jun 2024 17:03 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 10 Jun 2024 | Purchase | 9,704 | 13.71 | 133,042 | I |
| 10 Jun 2024 08:45 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 07 Jun 2024 | Purchase | 3,763 | 13.72 | 51,628 | I |
| 10 Jun 2024 08:45 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 06 Jun 2024 | Purchase | 9,598 | 13.8 | 132,452 | I |
| 05 Jun 2024 17:09 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 05 Jun 2024 | Purchase | 26,083 | 13.76 | 358,902 | I |
| 05 Jun 2024 17:09 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 04 Jun 2024 | Purchase | 33,357 | 13.5 | 450,320 | I |
| 03 Jun 2024 17:11 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 31 May 2024 | Purchase | 21,369 | 13.29 | 283,994 | I |
| 31 May 2024 15:08 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 30 May 2024 | Purchase | 669 | 13.05 | 8,730 | I |
| 31 May 2024 15:08 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 29 May 2024 | Purchase | 38,033 | 13.09 | 497,852 | I |
| 31 May 2024 15:08 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 28 May 2024 | Purchase | 8,714 | 13.38 | 116,593 | I |
| 23 May 2024 19:41 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 23 May 2024 | Purchase | 1,303 | 13.5 | 17,590 | I |
| 17 May 2024 12:34 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 15 May 2024 | Purchase | 34,755 | 14.19 | 493,173 | I |
| 14 May 2024 13:50 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 10 May 2024 | Purchase | 57,862 | 13.86 | 801,967 | I |
| 10 May 2024 10:31 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 09 May 2024 | Purchase | 17,373 | 13.8 | 239,747 | I |
| 10 May 2024 10:31 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 08 May 2024 | Purchase | 10,986 | 13.7 | 150,508 | I |
| 07 May 2024 17:07 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 07 May 2024 | Purchase | 50,161 | 13.76 | 690,215 | I |
| 07 May 2024 17:07 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 06 May 2024 | Purchase | 10,713 | 13.62 | 145,911 | I |
| 02 May 2024 16:50 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 02 May 2024 | Purchase | 26,274 | 13.46 | 353,648 | I |
| 02 May 2024 16:50 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 01 May 2024 | Purchase | 252 | 13.02 | 3,281 | I |
| 01 May 2024 10:23 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 30 Apr 2024 | Purchase | 16,573 | 13.13 | 217,603 | I |
| 29 Apr 2024 16:54 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 26 Apr 2024 | Purchase | 120,304 | 13 | 1,563,952 | I |
| 26 Apr 2024 11:40 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 24 Apr 2024 | Purchase | 20,529 | 13.12 | 269,340 | I |
| 26 Apr 2024 11:40 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 25 Apr 2024 | Purchase | 97,574 | 12.99 | 1,267,486 | I |
| 23 Apr 2024 20:00 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 23 Apr 2024 | Purchase | 48,203 | 13.15 | 633,869 | I |
| 23 Apr 2024 20:00 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 22 Apr 2024 | Purchase | 2,022 | 12.88 | 26,043 | I |
| 22 Apr 2024 15:08 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 19 Apr 2024 | Purchase | 42,459 | 12.84 | 545,174 | I |
| 22 Apr 2024 15:08 | HQL | abrdn Life Sciences Investors | SABA CAPITAL MANAGEMENT, L.P. | 10% | 18 Apr 2024 | Purchase | 81,738 | 12.8 | 1,046,246 | I |
| 12 Apr 2024 09:20 | HQL | abrdn Life Sciences Investors | GOETZ KATHLEEN | Director | 09 Apr 2024 | Purchase | 400 | 13.3183 | 5,327 | D |
| 04 Jan 2024 14:23 | HQL | abrdn Life Sciences Investors | REIT TODD | Director | 02 Jan 2024 | Purchase | 1,000 | 13.798 | 13,798 | D |
| 02 Jan 2024 16:34 | HQL | abrdn Life Sciences Investors | MAHER BILL | Director | 28 Dec 2023 | Purchase | 1,000 | 13.57 | 13,570 | D |
| 25 Sep 2023 17:35 | HQL | TEKLA LIFE SCIENCES INVESTORS | OMSTEAD DANIEL R | President | 25 Sep 2023 | Purchase | 10,096 | 12.3926 | 125,116 | D |
| 20 Sep 2023 18:40 | HQL | TEKLA LIFE SCIENCES INVESTORS | OMSTEAD DANIEL R | President | 20 Sep 2023 | Purchase | 12,000 | 12.6838 | 152,206 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)